Useful Advices - Business

Several years ago at a national conference, the speaker, David Herdlinger, applied his experience using the frequently quoted words, knowled

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ge, skills and attitudes and constructed KSA into a quadrant. The upper boxes contained the letters K for knowledge and A for attitudes.

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

n the lower left hand box was the letter S for Skills. To complete the quadrant, he added the letter H for Habits in the lower right hand corn

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

r. Now the letters K.A.S.H. fitted neatly into a box and Whoa La the K.A.S.H. Box was born.

The purpose of this K.A.S.H. Box<

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

b> was to show that more often than not performance failure whether organizationally or individually is not just an issue of knowledge and skil

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

s, but also poor attitudes and habits. Yet, individuals and organizations spend most of their resources developing knowledge and skills and fa

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

l to develop the necessary attitudes and habits for performance success.

Being an individual who is always looking to help others make more co

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

nnections, I expanded David’s K.A.S.H. Box into the nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

eChange.pdf">K.A.S.H. Box for Sustainable Change. Since the purpose of cash boxes is to accumulate daily change or profits within a change

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

rawer, I placed a large rectangular box under the quadrant. When cash is spent on the left side of the K.A.S.H. Box without investing cash on

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

he right side, the money is not reinvested into the business or individual, but is drained away. Hence, a negative return on investment happen

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

. When focusing on both sides of the K.A.S.H. Box, the efforts are reinvested into the change drawer and sustainable change happens.

Ho

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

many times have you witnessed the resources of energy, time and money being spent on a specific change initiative such as training or the impl

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

mentation of a quality program? And within a short time, the training must be redone or the quality program languishes and may even fail. Is th

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

e issue of one only of a lack of knowledge or skills or rather one of the desire, the want to?

Within this box, the left side (Knowledge and S

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ills) is all about learning – the acquisition of knowledge. While the right side (Attitudes and Habits) is all about performing – the

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

application of knowledge. The KASH Box also helps to explain the Knowing-Doing Gap(the Gap between the Actual Results and the

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

Desired Results).

So if you are truly interested in building your business from the small business to the Fortune 1000 by building your cash (

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

rofits), you may wish to embrace this model. And, remember to ask yourself this simple, but oh so telling question: Is the inability to achi

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ve the goals whether business, professional or personal due to the lack of knowledge or skills or because of some poor attitudes and habits?

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Useful Advices - Businesses Need to Build KASH To Secure the Desired End Results of Profits

Related Articles: